CRO recognized as a fastest-growing company
Wilmington, N.C., August 12, 2025 — Catalyst Clinical Research joined the 2025 Inc. 5000 list of the nation’s fastest-growing private companies. This year Catalyst earned a spot at 3,833 with 98% growth during the past three years.
“Being named to the Inc. 5000 list—our third major award recognition in 2025—underscores the strength of our strategy and the dedication of our global teams,” said Nik Morton, President and CEO of Catalyst Clinical Research. “As we continue to grow, our commitment to a people-first culture and delivering exceptional outcomes for our clients remains unwavering. These achievements reflect the trust our clients place in us and the passion our teams bring to inspiring people to design and deliver better clinical trials.”
“Making the Inc. 5000 is always a remarkable achievement, but earning a spot this year speaks volumes about a company’s tenacity and clarity of vision,” says Mike Hofman, editor-in-chief of Inc. “These businesses have thrived amid rising costs, shifting global dynamics, and constant change. They didn’t just weather the storm—they grew through it, and their stories are a powerful reminder that the entrepreneurial spirit is the engine of the U.S. economy.”
Founded in 2013, Catalyst has grown from one North Carolina-based office to hundreds of team members around the world. With our rapid growth, Catalyst Clinical Research has maintained a people-first culture, as evidenced by its industry-leading 12-month retention rate of 92% and 96% employee engagement score in the most recent calendar year.
Complete Inc. 5000 results, including company profiles sorted by industry, region, and other criteria, can be found at Inc.com/inc5000.
